GLP-1R/CRE Luciferase Reporter HEK293 Cell Line is an engineered HEK293 cell line expressing firefly luciferase under the control of cAMP response element (CRE), and human GLP-1R (Glucagon-like peptide 1 receptor; accession number BC113493). Activation of GLP-1R in these cells can be monitored by measuring luciferase activity.
The functionality of GLP-1R/CRE Luciferase Reporter HEK293 Cell Line was validated in dose-response assays using the peptide agonists Glucagon-like peptide 1 (7-37), Exendin-4, Lixisenatide, GLP-1 moiety from dulaglutide, Semaglutide, Tirzepatide and Retatrutide. This cell line has also been validated in a dose-response assay using a small molecule agonist, Danuglipron. GLP-1R/CRE Luciferase Reporter HEK293 Cell Line responds to agonists by inducing luciferase activity in a dose-dependent manner.
Created with BioRender.com
Figure 1. Illustration of mechanism of action in the GLP-1R/CRE Luciferase Reporter HEK293 Cell Line.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Response of GLP-1R/CRE Luciferase Reporter HEK293 Cell Line to Danuglipron is stable in the presence and absence of FBS.
更多详情：
http://www.bpsbioscience.com.cn/Products-37982132.html
https://www.chem17.com/st542058/product_37982132.html
